These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 3708035)

  • 1. Neuroendocrine responses in psychiatric and pain patients with major depression.
    Atkinson JH; Kremer EF; Risch SC; Dana R; Janowsky DS
    Biol Psychiatry; 1986 Jun; 21(7):612-20. PubMed ID: 3708035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Basal and post-dexamethasone cortisol and prolactin concentrations in depressed and non-depressed patients with chronic pain syndromes.
    Atkinson JH; Kremer EF; Risch SC; Janowsky DS
    Pain; 1986 Apr; 25(1):23-34. PubMed ID: 3714287
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Postdexamethasone prolactin and cortisol: a biological state variable in depression.
    Klein HE; Seibold B; Bender W; Nedopil N; Albus M; Schmauss M
    Acta Psychiatr Scand; 1984 Sep; 70(3):239-47. PubMed ID: 6496148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of dexamethasone on plasma prolactin and cortisol levels in psychiatric patients.
    Meltzer HY; Fang VS; Tricou BJ; Robertson A; Piyaka SK
    Am J Psychiatry; 1982 Jun; 139(6):763-8. PubMed ID: 7081489
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neuroendocrine aspects of primary endogenous depression. I. Cortisol secretory dynamics in patients and matched controls.
    Rubin RT; Poland RE; Lesser IM; Winston RA; Blodgett AL
    Arch Gen Psychiatry; 1987 Apr; 44(4):328-36. PubMed ID: 3566455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differentiation of depression from chronic pain with the dexamethasone suppression test and DSM-III.
    France RD; Krishnan KR; Houpt JL; Maltbie AA
    Am J Psychiatry; 1984 Dec; 141(12):1577-9. PubMed ID: 6239555
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Serum postdexamethasone prolactin measures in depressive patients and control subjects.
    Maes M; Schotte C; Peeters D; D'Hondt P; Martin M; Blockx P; Minner B; Suy E; Cosyns P
    J Psychiatr Res; 1991; 25(3):109-16. PubMed ID: 1941707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroendocrinological aspects of depression and symptomatological picture.
    Tosca P; Fenoglio L; Zerbi F; Romani A; Bezzi G; Ferrari E; Canepari C
    Psychiatr Clin (Basel); 1982; 15(3):153-9. PubMed ID: 7134486
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The dexamethasone suppression test in the clinical setting.
    Evans DL; Burnett GB; Nemeroff CB
    Am J Psychiatry; 1983 May; 140(5):586-9. PubMed ID: 6342422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prolactin in patients with major depressive disorder and in healthy subjects. I. Cross-sectional study of basal and post-TRH and postdexamethasone prolactin levels.
    Baumgartner A; Gräf KJ; Kürten I
    Biol Psychiatry; 1988 Jul; 24(3):249-67. PubMed ID: 3135847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroendocrine aspects of primary endogenous depression. V. Serum prolactin measures in patients and matched control subjects.
    Rubin RT; Poland RE; Lesser IM; Martin DJ
    Biol Psychiatry; 1989 Jan; 25(1):4-21. PubMed ID: 2492202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Psychopathology and plasma cortisol responses to dexamethasone in prepubertal psychiatric inpatients.
    Pfeffer CR; Stokes P; Weiner A; Shindledecker R; Faughnan L; Mintz M; Stoll PM; Heiligenstein E
    Biol Psychiatry; 1989 Nov; 26(7):677-89. PubMed ID: 2804189
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Measurement of ACTH and prolactin in the dexamethasone suppression test.
    Risch SC; Janowsky DS; Judd LL; Gillin JC; Mott MA; Rausch JL; Huey L
    Acta Psychiatr Scand; 1987 Nov; 76(5):535-40. PubMed ID: 2829509
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dissociation between pituitary and adrenal suppression to dexamethasone in depression.
    Young EA; Kotun J; Haskett RF; Grunhaus L; Greden JF; Watson SJ; Akil H
    Arch Gen Psychiatry; 1993 May; 50(5):395-403. PubMed ID: 8489328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Postdexamethasone plasma cortisol and beta-endorphin levels in depression: relationship to severity of illness.
    Meador-Woodruff JH; Haskett RF; Grunhaus L; Akil H; Watson SJ; Greden JF
    Biol Psychiatry; 1987 Sep; 22(9):1137-50. PubMed ID: 2958096
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DST in chronic pain patients not suffering from major depression.
    Magni G; Talamo Rossi R; Stella A; Mottaran R; Salar G
    Pharmacopsychiatry; 1989 Jan; 22(1):8-10. PubMed ID: 2710810
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationships of the dexamethasone suppression test to clinical severity and degree of melancholia.
    Kumar A; Alcser K; Grunhaus L; Greden JF
    Biol Psychiatry; 1986 May; 21(5-6):436-44. PubMed ID: 3697434
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal responses to fenfluramine in depressive subtypes.
    Mitchell P; Smythe G; Parker G; Wilhelm K; Hickie I; Brodaty H; Boyce P
    Br J Psychiatry; 1990 Oct; 157():551-7. PubMed ID: 2131137
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Age and the dexamethasone suppression test in depression.
    Davis KL; Davis BM; Mathé AA; Mohs RC; Rothpearl AB; Levy MI; Gorman LK; Berger P
    Am J Psychiatry; 1984 Jul; 141(7):872-4. PubMed ID: 6731636
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Influence of age on the cortisol response to dexamethasone.
    Lewis DA; Pfohl B; Schlechte J; Coryell W
    Psychiatry Res; 1984 Nov; 13(3):213-20. PubMed ID: 6597460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.